MD4009B1 - Utilizarea 1-metil-4-(N-metilaminobutil-4)-Beta-carbolinei in calitate de remediu antituberculos - Google Patents

Utilizarea 1-metil-4-(N-metilaminobutil-4)-Beta-carbolinei in calitate de remediu antituberculos Download PDF

Info

Publication number
MD4009B1
MD4009B1 MDA20080198A MD20080198A MD4009B1 MD 4009 B1 MD4009 B1 MD 4009B1 MD A20080198 A MDA20080198 A MD A20080198A MD 20080198 A MD20080198 A MD 20080198A MD 4009 B1 MD4009 B1 MD 4009B1
Authority
MD
Moldova
Prior art keywords
antituberculous
remedy
methylaminobutyl
carboline
beta
Prior art date
Application number
MDA20080198A
Other languages
English (en)
Other versions
MD4009C2 (ro
Inventor
Fliur MACAEV
Eugenia Stangaci
Daniela Duca
Gheorghe DUCA
Original Assignee
Institutul De Chimie Al Academiei De Stiinte A Moldovei
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Chimie Al Academiei De Stiinte A Moldovei filed Critical Institutul De Chimie Al Academiei De Stiinte A Moldovei
Priority to MDA20080198A priority Critical patent/MD4009C2/ro
Publication of MD4009B1 publication Critical patent/MD4009B1/ro
Publication of MD4009C2 publication Critical patent/MD4009C2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Inventia se refera la chimie, si anume la utilizarea compusului alcaloidului brevicarin in calitate de remediu antituberculos. Esenta inventiei consta in utilizarea 1-metil-4-(N-metilaminobutil-4)-Beta-carbolinei (brevicarina) cu formula generala:in calitate de remediu antituberculos.
MDA20080198A 2008-07-15 2008-07-15 Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos MD4009C2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080198A MD4009C2 (ro) 2008-07-15 2008-07-15 Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080198A MD4009C2 (ro) 2008-07-15 2008-07-15 Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos

Publications (2)

Publication Number Publication Date
MD4009B1 true MD4009B1 (ro) 2010-01-29
MD4009C2 MD4009C2 (ro) 2010-08-31

Family

ID=43568882

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080198A MD4009C2 (ro) 2008-07-15 2008-07-15 Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos

Country Status (1)

Country Link
MD (1) MD4009C2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4404C1 (ro) * 2015-03-18 2016-09-30 Институт Химии Академии Наук Молдовы Compusul 2-(propiltio)-5H-[1,3,4]tiadiazolo[2,3-b]chinazolin-5-onă, care manifestă activitate antituberculoasă şi procedeu de sinteză a acestuia

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4125C1 (ro) * 2010-09-17 2012-03-31 Inst De Chimie Al Academiei De Stiinte A Moldovei Compuşi 1,3,4-oxadiazolici cu proprietăţi antituberculoase conţinând tiouree monosubstituită

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU859889A1 (ru) * 1980-01-17 1981-08-30 Читинский Медицинский Институт Способ количественного определени 1-метил-4-(N-метилпирролидил-1)- -карболин гидрохлорида
US5817321A (en) * 1992-10-08 1998-10-06 Supratek Pharma, Inc. Biological agent compositions
ATE259825T1 (de) * 1999-03-23 2004-03-15 Hollis Eden Pharmaceuticals Hemihydrat von 16.alpha.-bromoepiandrosterone
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
UA71629C2 (en) * 1999-08-03 2004-12-15 Lilli Icos Llc Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
TW200403072A (en) * 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
UA78839C2 (en) * 2002-07-31 2007-04-25 Lilly Icos Llc Modified pictet-spengler reaction and products prepared therefrom
EP1626693A2 (en) * 2003-05-02 2006-02-22 Georgetown University Ginkgo biloba extract as a treatment for therapeutic- induced neurotoxicity
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
JO2524B1 (en) * 2004-05-28 2010-03-17 جانسن فارمسيتكا ان في Use of substituted quinoline derivatives to treat drug-resistant microbial diseases
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4404C1 (ro) * 2015-03-18 2016-09-30 Институт Химии Академии Наук Молдовы Compusul 2-(propiltio)-5H-[1,3,4]tiadiazolo[2,3-b]chinazolin-5-onă, care manifestă activitate antituberculoasă şi procedeu de sinteză a acestuia

Also Published As

Publication number Publication date
MD4009C2 (ro) 2010-08-31

Similar Documents

Publication Publication Date Title
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
MY153915A (en) Organic compounds
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
WO2007085895A3 (en) Fap inhibitors
MX2011007998A (es) Nuevos herbicidas.
WO2009024342A3 (en) Novel microbiocides
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
MY150542A (en) Cmet inhibitors
MY161132A (en) Novel herbicides
TN2010000064A1 (en) Novel herbicides
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
MX2012008141A (es) Compuestos y metodos.
MX2011007932A (es) Herbicidas nuevos.
WO2008151828A8 (en) Novel microbiocides
TN2011000355A1 (en) Novel microbiocides
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
UA101963C2 (en) 4-amino-pyrimidine derivatives
WO2009127718A3 (en) Novel microbiocides
TW200740814A (en) Compounds
IL189883A0 (en) Isoquinolines as igf-1r inhibitors
TW200700064A (en) Novel compounds
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
TN2009000536A1 (en) Novel herbicides

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees